Muscle Abnormalities in Nonhospitalised Patients With Post–COVID‐19 Condition
Andrea Tryfonos(Karolinska Institutet), Tommy R. Lundberg(Linköping University), Rodrigo Fernandez‐Gonzalo(Karolinska University Hospital), Michael Melin(Karolinska Institutet), Eric Rullman(Karolinska University Hospital), Anders P. Mutvei(Uppsala University), Alen Lovrić(Karolinska University Hospital), Veronika Tillander(Karolinska Institutet), Uwe J.F. Tietge(Karolinska University Hospital), Spyridon Pantelios(Karolinska Institutet), Sergio Díaz(Karolinska Institutet), Helena Wallin(Karolinska University Hospital), Helene Rundqvist(Karolinska University Hospital), Filip J. Larsen(Swedish School of Sport and Health Sciences), Per Stål(Karolinska University Hospital), Gustav Jörnåker(Karolinska Institutet), Thomas Gustafsson(Karolinska University Hospital), Kaveh Pourhamidi(Karolinska University Hospital), Douglas Crafoord(Karolinska Institutet), Håkan Rundqvist(Karolinska University Hospital)
Cited by 1
Related Papers
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
|Journal of Clinical Investigation|2004|620
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
|Journal of Clinical Investigation|2004|598
Exercise training during chemotherapy preserves skeletal muscle fiber area, capillarization, and mitochondrial content in patients with breast cancer
|The FASEB Journal|2018|158
HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase-Dependent Monocyte Chemoattractant Protein-1 Production
|Arteriosclerosis Thrombosis and Vascular Biology|2008|153
Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways
|Acta Physiologica|2019|122